11 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
targets at least $30 million in annualized cost reductions including a workforce reduction of approximately 15% (or approximately 100 employees … to the Company’s workforce of approximately 15% (or approximately 100 employees) which is anticipated to be completed in the fourth quarter of 2023
8-K
EX-2.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
to comply with any quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing, shut down, closure, sequester or any other
10-K
2020 FY
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
standards. In addition, as of December 31, 2020, approximately 20% of our workforce have earned advanced degrees and all receive rigorous training … Workforce
Our management includes experienced leaders with demonstrated records of success at Maravai and other highly regarded industry participants
424B4
yfxkm8k vz
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
2ih0zbzjv3478gf pb4
29 Oct 20
IPO registration
5:04pm
DRS/A
iguh2bk8vq
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
rle7jw laiyq
14 Oct 20
Draft registration statement (amended)
12:00am
DRS
qqfkry r52sfffjb
8 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next